|
right_atrial_end-systolic_area
|
right_atrial_end-systolic_area |
|
|
Cardiac_MRI_measurements
|
Cardiac_MRI_measurements |
|
|
20
|
20 |
|
|
valproic_acid
|
valproic_acid |
|
|
Poor
|
Poor |
|
|
27
|
27 |
|
|
Has_antiretroviral_therapy_been_changed_or_been_started_during_the_course_of_SARS-CoV-2_infection?
|
Has_antiretroviral_therapy_been_changed_or_been_started_during_the_course_of_SARS-CoV-2_infection? |
|
|
26
|
26 |
|
|
29
|
29 |
|
|
28
|
28 |
|
|
dihydralazine
|
dihydralazine |
|
|
Hypertensive disorder systemic arterial (disorder)
|
38341003 |
|
|
Sleep apnea
|
73430006 |
|
|
Prone position
|
GECCO_2.16.840.1.113883.3.1937.777.53.2.2.1820 |
[Bauchlage, Prone position] |
|
biological_attribute
|
biological_attribute |
|
|
Pseudomonas_aeruginosa_-_4MRGN
|
Pseudomonas_aeruginosa_-_4MRGN |
|
|
metamyelocyte
|
metamyelocyte |
|
|
Sonstige und nicht näher bezeichnete Gastroenteritis und Kolitis nicht näher bezeichneten Ursprungs
|
A09.9 |
|
|
Immunglobuline normal human zur extravasalen Anwendung
|
J06BA01 |
|
|
immunoglobulins
|
GECCO_1.2.276.0.76.11.500 |
[Medikamentöse Therapie mit Immunglobulinen im Rahmen von COVID-19] |
